Literature DB >> 29439156

Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD.

Takanori Komada1,2, Hyunjae Chung1,2, Arthur Lau1,2, Jaye M Platnich1,2, Paul L Beck1,2, Hallgrimur Benediktsson2,3, Henry J Duff4, Craig N Jenne2,5, Daniel A Muruve6,2.   

Abstract

Nonmicrobial inflammation contributes to CKD progression and fibrosis. Absent in melanoma 2 (AIM2) is an inflammasome-forming receptor for double-stranded DNA. AIM2 is expressed in the kidney and activated mainly by macrophages. We investigated the potential pathogenic role of the AIM2 inflammasome in kidney disease. In kidneys from patients with diabetic or nondiabetic CKD, immunofluorescence showed AIM2 expression in glomeruli, tubules, and infiltrating leukocytes. In a mouse model of unilateral ureteral obstruction (UUO), Aim2 deficiency attenuated the renal injury, fibrosis, and inflammation observed in wild-type (WT) littermates. In bone marrow chimera studies, UUO induced substantially more tubular injury and IL-1β cleavage in Aim2-/- or WT mice that received WT bone marrow than in WT mice that received Aim2-/- bone marrow. Intravital microscopy of the kidney in LysM(gfp/gfp) mice 5-6 days after UUO demonstrated the significant recruitment of GFP+ proinflammatory macrophages that crawled along injured tubules, engulfed DNA from necrotic cells, and expressed active caspase-1. DNA uptake occurred in large vacuolar structures within recruited macrophages but not resident CX3CR1+ renal phagocytes. In vitro, macrophages that engulfed necrotic debris showed AIM2-dependent activation of caspase-1 and IL-1β, as well as the formation of AIM2+ ASC specks. ASC specks are a hallmark of inflammasome activation. Cotreatment with DNaseI attenuated the increase in IL-1β levels, confirming that DNA was the principal damage-associated molecular pattern in this process. Therefore, the activation of the AIM2 inflammasome by DNA from necrotic cells drives a proinflammatory phenotype that contributes to chronic injury in the kidney.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  Immunology and pathology; chronic kidney disease; macrophages

Mesh:

Substances:

Year:  2018        PMID: 29439156      PMCID: PMC5875955          DOI: 10.1681/ASN.2017080863

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  58 in total

Review 1.  Mechanisms and functions of inflammasomes.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 2.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

3.  Necroptotic cells release find-me signal and are engulfed without proinflammatory cytokine production.

Authors:  Qiang Wang; Xiaoli Ju; Yang Zhou; Keping Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-06-20       Impact factor: 2.416

4.  NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis.

Authors:  H Chung; A Vilaysane; A Lau; M Stahl; V Morampudi; A Bondzi-Simpson; J M Platnich; N A Bracey; M-C French; P L Beck; J Chun; B A Vallance; D A Muruve
Journal:  Cell Death Differ       Date:  2016-02-19       Impact factor: 15.828

5.  The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury.

Authors:  Subramaniam Pennathur; Katie Pasichnyk; Nadia M Bahrami; Lixia Zeng; Maria Febbraio; Ikuyo Yamaguchi; Daryl M Okamura
Journal:  Am J Pathol       Date:  2015-06-16       Impact factor: 4.307

6.  Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.

Authors:  Ramanjaneyulu Allam; Christina Rebecca Scherbaum; Murthy Narayana Darisipudi; Shrikant R Mulay; Holger Hägele; Julia Lichtnekert; Jan Henrik Hagemann; Khader Valli Rupanagudi; Mi Ryu; Claudia Schwarzenberger; Bernd Hohenstein; Christian Hugo; Bernd Uhl; Christoph A Reichel; Fritz Krombach; Marc Monestier; Helen Liapis; Kristin Moreth; Liliana Schaefer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

7.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

8.  Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.

Authors:  Shuei Liong Lin; Ana P Castaño; Brian T Nowlin; Mark L Lupher; Jeremy S Duffield
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

9.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

10.  Primary mouse renal tubular epithelial cells have variable injury tolerance to ischemic and chemical mediators of oxidative stress.

Authors:  Anne C Breggia; Jonathan Himmelfarb
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

View more
  42 in total

Review 1.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

Review 2.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

Review 3.  Roles of pattern recognition receptors in diabetic nephropathy.

Authors:  Zhi-Feng Zhou; Lei Jiang; Qing Zhao; Yu Wang; Jing Zhou; Qin-Kai Chen; Jin-Lei Lv
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

4.  Quantification of Inflammasome Adaptor Protein ASC in Biological Samples by Multiple-Reaction Monitoring Mass Spectrometry.

Authors:  Annegret Ulke-Lemée; Arthur Lau; Michelle C Nelson; Matthew T James; Daniel A Muruve; Justin A MacDonald
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

5.  We AIM2 Inflame.

Authors:  Andreas Linkermann; Simon P Parmentier; Christian Hugo
Journal:  J Am Soc Nephrol       Date:  2018-03-06       Impact factor: 10.121

Review 6.  Inflammatory caspase regulation: maintaining balance between inflammation and cell death in health and disease.

Authors:  Beatriz E Bolívar; Tiphanie P Vogel; Lisa Bouchier-Hayes
Journal:  FEBS J       Date:  2019-05-27       Impact factor: 5.542

7.  dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury.

Authors:  Chintogtokh Baatarjav; Takanori Komada; Tadayoshi Karasawa; Naoya Yamada; Ariunaa Sampilvanjil; Takayoshi Matsumura; Masafumi Takahashi
Journal:  Cell Death Differ       Date:  2022-06-23       Impact factor: 15.828

Review 8.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

Review 9.  Inflammasome as an Effective Platform for Fibrosis Therapy.

Authors:  Ting-Ting Chen; Feng Xiao; Nan Li; Shan Shan; Meng Qi; Zi-Ying Wang; Sheng-Nan Zhang; Wei Wei; Wu-Yi Sun
Journal:  J Inflamm Res       Date:  2021-04-20

Review 10.  Pyroptosis: A New Frontier in Kidney Diseases.

Authors:  Ke-Jia Zhang; Qi Wu; Shi-Min Jiang; Lei Ding; Chao-Xia Liu; Ming Xu; Ying Wang; Yao Zhou; Li Li
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.